Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Background/Objectives: Despite the recent advances in glucose-lowering therapy, achieving diabetes control remains challenging. With the advancing progress of innovative digital health technologies, management of diabetes is taking advantage from telehealth and telemedicine, which allow for remote assistance, virtual visits, and monitoring of diabetes-related parameters, and facilitate the exchange of documents and reports to support clinical decisions. We aim to provide an overview of the impact of telehealth and digital technologies on the care of people with diabetes, from therapeutic management to the assessment of complications. Methods: A comprehensive literature search was conducted using PubMed to assess the impact of digital technologies and telemedicine on diabetes care. Results: From the comprehensive PubMed search, 86 peer-reviewed studies were selected based on relevance, clinical significance, and methodological quality. The selected literature addressed digital health tools such as continuous glucose monitoring, connected insulin pens, automatic insulin delivery systems, mobile applications, and telemedicine systems. These interventions were associated with improved glycemic control (e.g., reduced HbA1c, increased time in range), better adherence to therapy, enhanced patient engagement, and more efficient management of complications such as neuropathy, retinopathy, and cardiovascular risk. Conclusions: Telehealth may offer a fully patient-centered approach to disease management through a tailored individual management plan. This may lead to an improvement in adherence to proper therapy and lifestyle, resulting in a subsequent increase in the quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By integrating sensing technology, mobile computing, data analytics, and remote communication. DHT enables continuous disease state monitoring, real-time behavioral interventions, and efficient patient-provider communication [9–12].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [11]
In the citing paper
“Against this backdrop, digital health technology (DHT) has the potential to address the aforementioned care gaps in people with EOT2D [9–12].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01301-6 · Cited by 6,146
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104 · cited 2×
“Additionally, the management of DM has to address not only glucose-lowering therapy but also the control of the other cardiovascular risk factors and related comorbidities [3].”
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 1×
“Glucose monitoring plays a key role in both the treatment and management of insulin-treated PwD [19,20].”
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 1×
“Few studies have evaluated the effect of rtCGM compared with usual care in people with T2DM [27,33] or in pregnant women with T1DM on intensive insulin regimen [34], with encouraging results.”
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652 · cited 1×
“These technologies initially enabled the glucose-responsive regulation of insulin delivery to address hypoglycemia [46,47].”
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644 · cited 1×
“Studies focusing on various AID systems with different algorithms, pumps, and sensors have been conducted in both adults and children with diabetes [48–51].”
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · cited 1×
“However, there is evidence that isCGM with optional alarms is associated with a reduction in HbA1c in people with T1DM [35] and a decreased rate of hypoglycemia in T2DM [36,37].”
Darkins, A., Ryan, P., Kobb, R., Foster, L., Edmonson, E., Wakefield, B., & Lancaster, A. E. (2008) · Telemedicine and e-Health · doi:10.1089/tmj.2008.0021 · Cited by 597
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543 · cited 1×
“The benefits were more significant in PwD who employed the sensor for an extended period [22–31].”
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 1×
“The results showed substantial benefits associated with the use of rtCGM in adults of all ages, as long as participants in the studies continued to use the device [32].”
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
Iglay, K., Hannachi, H., Joseph Howie, P., Xu, J., Li, X., Engel, S. S., Moore, L. M., & Rajpathak, S. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1168291 · Cited by 511
the SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Weisman, A., Bai, J.-W., Cardinez, M., Kramer, C. K., & Perkins, B. A. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30167-5 · Cited by 463 · cited 1×
“Meta-analysis of RCTs provides evidence that AID systems may improve TIR, reduce hyperglycemia and hypoglycemia and modestly decrease HbA1c levels, compared with control therapy (conventional pump therapy or sensor-augmented pump therapy) [52,53].”
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., Schoelwer, M., Ruedy, K. J., Jost, E., Carria, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004736 · Cited by 455
Tauschmann, M., Thabit, H., Bally, L., Allen, J. M., Hartnell, S., Wilinska, M. E., Ruan, Y., Sibayan, J., Kollman, C., Cheng, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31947-0 · Cited by 440
Bekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T., Haidich, A.-B., Hovorka, R., & Tsapas, A. (2018) · BMJ · doi:10.1136/bmj.k1310 · Cited by 437
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411 · cited 1×
“Most studies identified the reduction in HbA1c as the primary outcome associated with the use of apps, compared with control strategies [59–62 ,64].”
van Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386
Pratley, R. E., Kanapka, L. G., Rickels, M. R., Ahmann, A., Aleppo, G., Beck, R., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.6928 · Cited by 375
Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D., & Esposito, K. (2020) · Diabetes Care · doi:10.2337/dc19-1459 · Cited by 364
Self-citationFleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0771 · Cited by 246 · cited 1×
“These technologies initially enabled the glucose-responsive regulation of insulin delivery to address hypoglycemia [46,47].”
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019) · Telemedicine and e-Health · doi:10.1089/tmj.2018.0128 · Cited by 239
Little, S. A., Leelarathna, L., Walkinshaw, E., Tan, H. K., Chapple, O., Lubina-Solomon, A., Chadwick, T. J., Barendse, S., Stocken, D. D., Brennand, C., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0030 · Cited by 237
Intermittently scanned continuous glucose monitoring for type 1 diabetes
Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205650 · Cited by 174 · cited 1×
“However, there is evidence that isCGM with optional alarms is associated with a reduction in HbA1c in people with T1DM [35] and a decreased rate of hypoglycemia in T2DM [36,37].”
Su, D., Zhou, J., Kelley, M. S., Michaud, T. L., Siahpush, M., Kim, J., Wilson, F., Stimpson, J. P., & Pagán, J. A. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.019 · Cited by 164 · cited 3×
“Several interventions in telemedicine have proved to significantly improve systolic and diastolic blood pressure, triglycerides, and total cholesterol serum levels [82].”
InfluentialAdolfsson, P., Hartvig, N. V., Kaas, A., Møller, J. B., & Hellman, J. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0411 · Cited by 139 · cited 1×
“Emerging evidence suggests that the use of connected insulin pens is associated with increased TIR and fewer missed boluses in T1DM treated with a basal-bolus insulin regimen [42], indicating a beneficial impact on glucose control and dosing behavior [43].”
Phillip, M., Bergenstal, R. M., Close, K. L., Danne, T., Garg, S. K., Heinemann, L., Hirsch, I. B., Kovatchev, B. P., Laffel, L. M., Mohan, V., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0375 · Cited by 135 · cited 2×
“Numerous guidelines or international panels have identified three key areas of application for telemedicine in diabetes care to improve patients’ outcomes, increase access to care and reduce costs: 1. secondary prevention; 2. diagnosis; and 3. treatment [6,12].”
Hou, C., Xu, Q., Diao, S., Hewitt, J., Li, J., & Carter, B. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13307 · Cited by 127
Eberle, C., & Stichling, S. (2021) · Journal of Medical Internet Research · doi:10.2196/23244 · Cited by 119
Shared decision making in endocrinology: Present and future directions
Rodriguez-Gutierrez, R., Gionfriddo, M. R., Ospina, N. S., Maraka, S., Tamhane, S., Montori, V. M., & Brito, J. P. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00468-4 · Cited by 117
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Jackson, M. A., Ahmann, A., & Shah, V. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0007 · Cited by 106 · cited 1×
“Few studies have evaluated the effect of rtCGM compared with usual care in people with T2DM [27,33] or in pregnant women with T1DM on intensive insulin regimen [34], with encouraging results.”
Lee, E. Y., Cha, S.-A., Yun, J.-S., Lim, S.-Y., Lee, J.-H., Ahn, Y.-B., Yoon, K.-H., Hyun, M. K., & Ko, S.-H. (2022) · Journal of Medical Internet Research · doi:10.2196/37430 · Cited by 83
Macdonald, E. M., Perrin, B. M., & Kingsley, M. I. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x17699990 · Cited by 53 · cited 1×
“The results showed an equivalence of these approaches for the remote management of diabetic patients; however, it is imperative to adapt each of them to the specific needs of each patient [14].”
Digital Interventions for Psychological Comorbidities in Chronic Diseases—A Systematic Review
Maisto, M., Diana, B., Di Tella, S., Matamala-Gomez, M., Montana, J. I., Rossetto, F., Mavrodiev, P. A., Cavalera, C., Blasi, V., Mantovani, F., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010030 · Cited by 30 · cited 1×
“A systematic review [114] including seventeen RCTs evaluated the effectiveness of digital tools in mental illness management in chronic diseases such as cardiovascular diseases, chronic obstructive pulmonary disease (COPD), stroke and diabetes.”
Crossen, S., Romero, C., Reggiardo, A., Michel, J., & Glaser, N. (2022) · JMIR Diabetes · doi:10.2196/33639 · Cited by 21 · cited 1×
“Several clinical trials focusing on interventions based on apps to manage diabetes have been conducted in various population, including in children and adolescents with T1DM [57,58], adults with both T1DM and T2DM [59–62] and women with pregnancy diabetes [63].”
Cai, J., Xu, H., Jiang, S., Sung, J., Sawhney, R., Broadley, S., & Sun, J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110727 · Cited by 8 · cited 2×
“Moreover, a recent meta-analysis of 30 RCTs, including 4678 PwD, reported that system practicality, user engagement, patient characteristics and disease education are the main factors influencing the effect of telemonitoring on glucose control [70].”
Research works printed but not linked: 68
- Giugliano, 2019, Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes, J. Endocrinol. Invest., 42, 495, 10.1007/s40618-018-0951-8 · DOI
- Peyrot, 2005, Psychosocial problems and barriers to improved diabetes management: Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study, Diabet. Med., 22, 1379, 10.1111/j.1464-5491.2005.01644.x · DOI · Paper page
- Peyrot, 2013, Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care, Diabetes Res. Clin. Pract., 99, 174, 10.1016/j.diabres.2012.11.016 · DOI · Paper page
- Raposo, 2021, Identifying the unmet needs of individuals with Type 2 diabetes: An international web-based survey, J. Comp. Eff. Res., 10, 613, 10.2217/cer-2020-0271 · DOI
- Wannheden, 2022, Digital Health Technologies Enabling Partnerships in Chronic Care Management: Scoping Review, J. Med. Internet Res., 24, e38980, 10.2196/38980 · DOI
- Lee, 2018, Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review, Diabetes Technol. Ther., 20, 492, 10.1089/dia.2018.0098 · DOI · Paper page
- Mars, 2013, Telemedicine and advances in urban and rural healthcare delivery in Africa, Prog. Cardiovasc. Dis., 56, 326, 10.1016/j.pcad.2013.10.006 · DOI · Paper page
- Battelino, 2011, Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes, Diabetes Care, 34, 795, 10.2337/dc10-1989 · DOI · Paper page
- Yaron, 2019, Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes, Diabetes Care, 42, 1178, 10.2337/dc18-0166 · DOI · Paper page
- Maddaloni, 2020, Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data from People with Diabetes on Intensive Insulin Therapy, Diabetes Care, 43, e86, 10.2337/dc20-0954 · DOI
- Capaldo, 2020, Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes, Diabetes Care, 43, e88, 10.2337/dc20-1127 · DOI
- Maiorino, 2023, LIVE CGM working group. An. updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes, Endocrine, 82, 215, 10.1007/s12020-023-03473-w · DOI
- Edwards, 2022, Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes, Diabetes Technol. Ther., 24, 61, 10.1089/dia.2021.0239 · DOI
- Jendle, 2021, Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis, Diabetes Ther., 12, 373, 10.1007/s13300-020-00980-1 · DOI · Paper page
- Chien, 2023, Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system, J. Manag. Care Spec. Pharm., 29, 285
- Ware, 2022, Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes, N. Engl. J. Med., 386, 209, 10.1056/NEJMoa2111673 · DOI · Paper page
- Sherr, 2023, Automated insulin delivery: Benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association, Diabetologia, 66, 3, 10.1007/s00125-022-05744-z · DOI · Paper page
- Bergenstal, 2008, Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine, Diabetes Care, 31, 1305, 10.2337/dc07-2137 · DOI · Paper page
- Conroy, 2014, Behavior change techniques in top-ranked mobile apps for physical activity, Am. J. Prev. Med., 46, 649, 10.1016/j.amepre.2014.01.010 · DOI · Paper page
- Goyal, 2017, A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial, JMIR Mhealth Uhealth, 5, e82, 10.2196/mhealth.7336 · DOI · Paper page
- Grady, 2017, Diabetes App-Related Text Messages From Health Care Professionals in Conjunction With a New Wireless Glucose Meter With a Color Range Indicator Improves Glycemic Control in Patients With Type 1 and Type 2 Diabetes: Randomized Controlled Trial, JMIR Diabetes, 2, e19, 10.2196/diabetes.7454 · DOI
- Lim, 2021, Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults with Type 2 Diabetes: A Randomized Clinical Trial, JAMA Netw Open, 4, e2112417, 10.1001/jamanetworkopen.2021.12417 · DOI · Paper page
- Eberle, C., Loehnert, M., and Stichling, S. (2021). Effectivness of specific mobile health applications (mHealth-apps) in gestational diabtetes mellitus: A systematic review. BMC Pregnancy Childbirth, 21. · DOI
- Chong, C.J., Bakry, M.M., Hatah, E., Mohd Tahir, N.A., and Mustafa, N. (2023). Effects of mobile apps intervention on medication adherence and type 2 diabetes mellitus control: A systematic review and meta-analysis. J. Telemed. Telecare, 1357633X231174933. · DOI
- Zhou, 2014, Web-based telemedicine for management of type 2 diabetes through glucose uploads: A randomized controlled trial, Int. J. Clin. Exp. Pathol., 7, 8848
- Moattari, 2013, The impact of electronic education on metabolic control indicators in patients with diabetes who need insulin: A randomised clinical control trial, J. Clin. Nurs., 22, 32, 10.1111/j.1365-2702.2012.04200.x · DOI · Paper page
- Pacaud, 2012, Successful Delivery of Diabetes Self-Care Education and Follow-Up through eHealth Media, Can. J. Diab., 36, 257, 10.1016/j.jcjd.2012.08.006 · DOI
- Nicolucci, 2015, A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes, Diabetes Technol. Ther., 17, 563, 10.1089/dia.2014.0355 · DOI · Paper page
- Franc, 2020, DIABEO System Combining a Mobile App Software with and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen, Diabetes Technol. Ther., 22, 904, 10.1089/dia.2020.0021 · DOI · Paper page
- Wild, S.H., Hanley, J., Lewis, S.C., McKnight, J.A., McCloughan, L.B., Padfield, P.L., Parker, R.A., Paterson, M., Pinnock, H., and Sheikh, A. (2016). Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial. PLoS Med., 13. · DOI
- Talha, 2018, Experimentation of 2.0 telemedicine in elderly patients with chronic heart failure: A study prospective in 175 patients, Eur. J. Intern. Med., 51, e11, 10.1016/j.ejim.2018.02.022 · DOI
- Kaufman, 1999, Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic, Pediatrics, 103, 948, 10.1542/peds.103.5.948 · DOI · Paper page
- Kassar, 2017, Use of Telemedicine for Management of Diabetes in Correctional Facilities, Telemed. J. E Health, 23, 55, 10.1089/tmj.2016.0036 · DOI
- Tonyushkina, 2018, Televisits to Partially Substitute for Clinic Visits Are Feasible and Well Accepted by Tech-Savvy Patients With T1DM and Their Families: A Prospective Pilot Study, J. Diabetes Sci. Technol., 12, 1084, 10.1177/1932296818775438 · doi:10.1177/1932296818775438
- Greenfield, 2022, Diabetes Education and Support Tele-Visit Needs Differ in Duration, Content, and Satisfaction in Older Versus Younger Adults, Telemed. Rep., 3, 107
- Pintaudi, 2021, First televisits provided by the public health system for patients affected by diabetes mellitus in COVID-19 pandemic, Diabetes Res. Clin. Pract., 173, 108697, 10.1016/j.diabres.2021.108697 · DOI
- Scott, 2022, Use and Perception of Telemedicine in People with Type 1 Diabetes During the COVID-19 Pandemic: A 1-Year Follow-Up, Diabetes Technol Ther., 24, 276, 10.1089/dia.2021.0426 · DOI
- Cheng, 2021, Telemedicine assists in the management of proatherogenic dyslipidemia and postprandial glucose variability in patients with type 2 diabetes mellitus: A cross-sectional study, Endocr. Connect., 10, 789, 10.1530/EC-21-0209 · DOI
- Yatabe, 2021, Efficacy of Telemedicine in Hypertension Care Through Home Blood Pressure Monitoring and Videoconferencing: Randomized Controlled Trial, JMIR Cardio., 5, e27347, 10.2196/27347 · DOI
- Salisbury, 2016, Telehealth for patients at high risk of cardiovascular disease: Pragmatic randomised controlled trial, BMJ, 353, i2647, 10.1136/bmj.i2647 · DOI · Paper page
- Lieber, 2015, Meta-analysis of telemonitoring to improve HbA1c levels: Promise for stroke survivors, J. Clin. Neurosci., 22, 807, 10.1016/j.jocn.2014.11.009 · DOI · Paper page
- Rasmussen, 2015, A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers, Diabetes Care, 38, 1723, 10.2337/dc15-0332 · DOI · Paper page
- Igland, 2018, The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial, Diabetes Care, 41, 96, 10.2337/dc17-1025 · DOI
- Iversen, M.M., Igland, J., Smith-Strøm, H., Østbye, T., Tell, G.S., Skeie, S., Cooper, J.G., Peyrot, M., and Graue, M. (2020). Effect of a telemedicine intervention for diabetes-related foot ulcers on health, well-being and quality of life: Secondary outcomes from a cluster randomized controlled trial (DiaFOTo). BMC Endocr. Disord., 20. · DOI
- Wilbright, 2004, The use of telemedicine in the management of diabetes-related foot ulceration: A pilot study, Adv. Skin Wound Care, 17, 232, 10.1097/00129334-200406000-00012 · DOI · Paper page
- Kim, 2004, Patient attitudes toward a Web-based system for monitoring chronic wounds, Telemed. J. E Health, 10, S-26, 10.1089/1530562042632074 · DOI
- Bowling, 2009, An assessment of the accuracy and usability of a novel optical wound measurement system, Diabet. Med., 26, 93, 10.1111/j.1464-5491.2008.02611.x · doi:10.1111/j.1464-5491.2008.02611.x
- Ladyzynski, 2011, Area of the diabetic ulcers estimated applying a foot scanner-based home telecare system and three reference methods, Diabetes Technol. Ther., 13, 1101, 10.1089/dia.2011.0082 · DOI
- Bowling, 2011, Remote assessment of diabetic foot ulcers using a novel wound imaging system, Wound Repair. Regen., 19, 25, 10.1111/j.1524-475X.2010.00645.x · DOI
- Rajbhandari, 1999, Digital imaging: An accurate and easy method of measuring foot ulcers, Diabet. Med., 16, 339, 10.1046/j.1464-5491.1999.00053.x · DOI
- Hazenberg, 2014, Assessment of signs of foot infection in diabetes patients using photographic foot imaging and infrared thermography, Diabetes Technol. Ther., 16, 370, 10.1089/dia.2013.0251 · DOI · Paper page
- Armstrong, 2007, Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients, Am. J. Med., 120, 1042, 10.1016/j.amjmed.2007.06.028 · DOI · Paper page
- Lavery, 2004, Home monitoring of foot skin temperatures to prevent ulceration, Diabetes Care, 27, 2642, 10.2337/diacare.27.11.2642 · DOI · Paper page
- Lavery, 2007, Preventing diabetic foot ulcer recurrence in high-risk patients: Use of temperature monitoring as a self-assessment tool, Diabetes Care, 30, 14, 10.2337/dc06-1600 · DOI · Paper page
- Skafjeld, A., Iversen, M.M., Holme, I., Ribu, L., Hvaal, K., and Kilhovd, B.K. (2015). A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes--a randomized controlled trial. BMC Endocr. Disord., 15. · DOI
- Stess, 1986, Use of liquid crystal thermography in the evaluation of the diabetic foot, Diabetes Care, 9, 267, 10.2337/diacare.9.3.267 · DOI
- Benbow, 1994, The prediction of diabetic neuropathic plantar foot ulceration by liquid-crystal contact thermography, Diabetes Care, 17, 835, 10.2337/diacare.17.8.835 · doi:10.2337/diacare.17.8.835
- Roback, 2009, Feasibility of a thermographic method for early detection of foot disorders in diabetes, Diabetes Technol. Ther., 11, 663, 10.1089/dia.2009.0053 · doi:10.1089/dia.2009.0053
- Frykberg, 2017, Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers, Diabetes Care, 40, 973, 10.2337/dc16-2294 · DOI · Paper page
- Rajbhandari, 1999, Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer, Diabetes Care, 22, 1292, 10.2337/diacare.22.8.1292 · DOI
- Papazoglou, E.S., Neidrauer, M., Zubkov, L., Weingarten, M.S., and Pourrezaei, K. (2009). Noninvasive assessment of diabetic foot ulcers with diffuse photon density wave methodology: Pilot human study. J. Biomed. Opt., 14. · DOI
- Neidrauer, 2010, Near infrared wound monitor helps clinical assessment of diabetic foot ulcers, J. Diabetes Sci. Technol., 4, 792, 10.1177/193229681000400404 · DOI
- Weingarten, 2010, Prediction of wound healing in human diabetic foot ulcers by diffuse near-infrared spectroscopy: A pilot study, Wound Repair. Regen., 18, 180, 10.1111/j.1524-475X.2010.00583.x · DOI
- Weingarten, 2012, Diffuse near-infrared spectroscopy prediction of healing in diabetic foot ulcers: A human study and cost analysis, Wound Repair. Regen., 20, 911, 10.1111/j.1524-475X.2012.00843.x · DOI
- Nouvong, 2009, Evaluation of diabetic foot ulcer healing with hyperspectral imaging of oxyhemoglobin and deoxyhemoglobin, Diabetes Care, 32, 2056, 10.2337/dc08-2246 · DOI · Paper page
- Khaodhiar, 2007, The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes, Diabetes Care, 30, 903, 10.2337/dc06-2209 · DOI · Paper page
- Jaser, 2011, Coping and resilience in adolescents with type 1 diabetes, Child Care Health Dev., 37, 335, 10.1111/j.1365-2214.2010.01184.x · DOI · Paper page
- Iturralde, 2017, Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics, J. Adolesc. Health, 61, 591, 10.1016/j.jadohealth.2017.05.030 · DOI
Cited by
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Maida, E., Caruso, P., Bonavita, S., Abbadessa, G., Miele, G., Longo, M., Scappaticcio, L., Ruocco, E., Trojsi, F., Esposito, K., Lavorgna, L., & Maiorino, M. I.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2025-06-14
- Volume
- 14
- Issue
- 12
- Pages
- 4240
- ISSN
- 2077-0383
- Cited by
- 15
- References
- 43
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.